Brodalumab Versus Guselkumab in Patients with Moderate-to-Severe Psoriasis with an Inadequate Response to Ustekinumab : A Randomized, Multicenter, Double-Blind Phase 4 Trial (COBRA) - Reich, Kristian (University Medical Center Hamburg-Eppendorf, Hamburg, Germany) ; Bianchi, Luca (U.O.S.D. di Dermatologia Fondazione PTV Policlinico Tor Vergata, Rome, Italy) ; Khemis, Abdallah (Polyclinique Saint George, Groupe KANTYS, Nice, France) ; Maul, Julia-Tatjana (University of Zürich) ; Tsianakas, Athanasios (Fachklinik Bad Bentheim, Bad Bentheim, Germany) ; Schempp, Christoph M. (University of Freiburg, Germany) ; Petersen, Kim (LEO Pharma A/S, Ballerup, Denmark) ; Noergaard, Mia M. (LEO Pharma A/S, Ballerup, Denmark) ; Puig Sanz, Lluís (Hospital de la Santa Creu i Sant Pau (Barcelona, Catalunya)) ; Universitat Autònoma de Barcelona. Departament de Medicina